Bright Minds Biosciences Inc. Gains 132.71%
Mon, Oct 14, 2024 at 07:08 PM
Bright Minds Biosciences Inc. (DRUG:NASDAQ) soared at $2.49, representing a gain of 132.7%. On Mon, Oct 14, 2024, DRUG:NASDAQ hit a New 2-Week High of $2.49. The stock appeared on our News Catalysts scanner on Thu, Sep 19, 2024 at 01:55 PM in the 'MISCELLANEOUS' category. From Mon, Sep 30, 2024, the stock recorded 50.00% Up Days and 36.36% Green Days
About Bright Minds Biosciences Inc. (DRUG:NASDAQ)
Bright Minds Biosciences Inc is focused on developing novel transformative treatments for neuropsychiatric disorders, epilepsy, and pain.
Top 10 Gainers:
- Reneo Pharmaceuticals Inc. (RPHM:NASDAQ), 952.02%
- Tevogen Bio Holdings Inc Com (TVGN:NASDAQ), 187.14%
- Bright Minds Biosciences Inc. (DRUG:NASDAQ), 132.71%
- Verb Technology Company, Inc. (VERB:NASDAQ), 58.41%
- Rani Therapeutics Holdings Inc. (RANI:NASDAQ), 57.43%
- Longboard Pharmaceuticals Inc. (LBPH:NASDAQ), 51.65%
- Expion360 Inc. (XPON:NASDAQ), 47.28%
- Vision Marine Technologies Inc. (VMAR:NASDAQ), 44.1%
- Inventiva S.A. (IVA:NASDAQ), 41.27%
- Big Tree Cloud Holdings Limited (DSY:NASDAQ), 38.9%